Rituximab for autoimmune blistering diseases: recent studies, new insights

被引：0
作者：
Lunardon, L. [1 ]
Payne, A. S. [1 ]
机构：
[1] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
来源：
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA | 2012年 / 147卷 / 03期
基金：
美国国家卫生研究院;
关键词：
Autoimmunity; Skin diseases; Pemphigus; EPIDERMOLYSIS-BULLOSA ACQUISITA; B-CELL DEPLETION; METHYLPREDNISOLONE PLUS AZATHIOPRINE; PEMPHIGUS-VULGARIS; MYCOPHENOLATE-MOFETIL; BONE-MARROW; CONSENSUS STATEMENT; ADJUVANT TREATMENT; ANTI-CD20; THERAPY;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Rituximab, an anti-CD20 monoclonal antibody, has been successfully used off-label for treatment of autoimmune blistering diseases. We discuss rituximab mechanisms of action, host factors that may affect response to rituximab, and the efficacy and safety of rituximab in autoimmune blistering diseases, incorporating recent data on the use of rituximab in other autoimmune disease patients.
引用
收藏
页码：269 / 276
页数：8
相关论文
共 70 条
[1]   Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin [J].
Ahmed, A. Razzaque ;
Spigelman, Zachary ;
Cavacini, Lisa A. ;
Posner, Marshall R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17) :1772-1779
[2]   Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases [J].
Ahmed, AR ;
Dahl, MV .
ARCHIVES OF DERMATOLOGY, 2003, 139 (08) :1051-1059
[3]   Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus [J].
Albert, D. ;
Dunham, J. ;
Khan, S. ;
Stansberry, J. ;
Kolasinski, S. ;
Tsai, D. ;
Pullman-Mooar, S. ;
Barnack, F. ;
Striebich, C. ;
Looney, R. J. ;
Prak, E. T. Luning ;
Kimberly, R. ;
Zhang, Y. ;
Eisenberg, R. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) :1724-1731
[4]   Rituximab in the Treatment of Bullous Systemic Lupus Erythematosus [J].
Alsanafi, Shamael ;
Kovarik, Carrie ;
Mermelstein, Andrew L. ;
Werth, Victoria P. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (03) :142-144
[5]   The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus [J].
Anolik, JH ;
Campbell, D ;
Felgar, RE ;
Young, F ;
Sanz, I ;
Rosenblatt, J ;
Looney, RJ .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :455-459
[6]   A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid [J].
Beissert, Stefan ;
Werfel, Thomas ;
Frieling, Uta ;
Boehm, Markus ;
Sticherling, Michael ;
Stadler, Rudolf ;
Zillikens, Detlef ;
Rzany, Berthold ;
Hunzelmann, Nicolas ;
Meurer, Michael ;
Gollnick, Harald ;
Ruzicka, Thomas ;
Pillekhamp, Hans ;
Junghans, Volker ;
Bonsmann, Gisela ;
Luger, Thomas A. .
ARCHIVES OF DERMATOLOGY, 2007, 143 (12) :1536-1542
[7]   A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus [J].
Beissert, Stefan ;
Werfel, Thomas ;
Frieling, Uta ;
Boehm, Markus ;
Sticherling, Michael ;
Stadler, Rudolf ;
Zillikens, Detlev ;
Rzany, Berthold ;
Hunzelmann, Nicolas ;
Meurer, Michael ;
Gollnick, Harald ;
Ruzicka, Thomas ;
Pillekamp, Hans ;
Junghans, Volker ;
Luger, Thomas A. .
ARCHIVES OF DERMATOLOGY, 2006, 142 (11) :1447-1454
[8]   Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial [J].
Beissert, Stefan ;
Mimouni, Daniel ;
Kanwar, Amrinder J. ;
Solomons, Neil ;
Kalia, Veena ;
Anhalt, Grant J. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (08) :2041-2048
[9]   Pharmacokinetics of rituximab and its clinical use: Thought for the best use? [J].
Cartron, Guillaume ;
Blasco, Helene ;
Paintaud, Gilles ;
Watier, Herve ;
Le Guellec, Chantal .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (01) :43-52
[10]   The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators [J].
Chan, LS ;
Ahmed, AR ;
Anhalt, GJ ;
Bernauer, W ;
Cooper, KD ;
Elder, MJ ;
Fine, JD ;
Foster, S ;
Ghohestani, R ;
Hashimoto, T ;
Hoang-Xuan, T ;
Kirtschig, G ;
Korman, NJ ;
Lightman, S ;
Lozado-Nur, F ;
Marinkovich, MP ;
Mondino, BJ ;
Prost-Squarcioni, C ;
Rogers, RS ;
Setterfield, JF ;
West, DP ;
Wojnarowska, F ;
Woodley, DT ;
Yancey, KB ;
Zillikens, D ;
Zone, JJ .
ARCHIVES OF DERMATOLOGY, 2002, 138 (03) :370-379
1234567